Wall Street Analysts Believe Corbus Pharmaceuticals (CRBP) Could Rally 54.24%: Here's is How to Trade

Corbus Pharmaceuticals (CRBP) closed the last trading session at $53.60, gaining 0.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 82.67 indicates a 54.2% upside potential. The average comprises six short-term price targets ranging from a low of $76 to a high of$ 88, with a standard deviation of $4.27. While the lowest estimate indicates an increase of 41.8% from the current pr ...